Company Directory > Biotech > Laboratorios Viñas
Laboratorios Viñas is a family-owned Spanish pharmaceutical company founded in Barcelona in 1911. The company specializes in the research, development, manufacture, and marketing of pharmaceutical products across several therapeutic areas, with a primary focus on dermatology, gynecology, pediatrics, and general medicine. It is recognized for its commitment to innovation, maintaining its own R&D center and industrial complex capable of producing 15 million units annually. The company is a participant in Spain's Profarma Plan, which promotes competitiveness and research in the pharmaceutical industry. With a portfolio that includes well-known brands like Emolienta, Tanit, and Vitacrecil, Laboratorios Viñas has a significant presence in the Spanish market and is actively expanding its international footprint through local distributors and strategic partnerships.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Dermatology and Consumer Healthcare
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:1911
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Topical formulations, Nutraceuticals
Active Trials:2
Trial Phases:Phase 3: 1 | Phase 4: 1
FDA Approvals:0
EMA Approvals:5
CORPORATE STRUCTURE
Key Partnerships:ICEX (Spanish Institute for Foreign Trade) for international expansion, Various local distributors in China, Belgium, and Switzerland
COMPETITION
Position:Niche Player
Competitors:Almirall, Isdin, Ferrer, Laboratorios Cantabria, Uriach
LEADERSHIP
Key Executives:
Antonio Buxadé Viñas - CEO
Mariano Buxadé Viñas - CEO
Mariona Buxadé Hernanz - Business Development Manager
Scientific Founders:Pedro Viñas
Board Members:Gemma Buxadé Viñas, Ignasi Buxadé Valle, Ana Sainz
LINKS
Website:vinas.es
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Laboratorios Viñas. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.